自2020年9月投资合肥晶合集成以来，上峰水泥（000672）在半导体、新能源、新材料领域稳健开展股 权投资，目前累计投资超17亿元，尤其半导体投资的系列国产替代龙头，以及新能源新材料各独角兽快 速成长，在每年为公司带来财务收益的同时，更是在新质产业培育方向为公司"双轮驱动"奠定坚实基 础，上峰发布的新五年规划也清晰明确了以股权投资业务助力第二成长曲线业务发展的总目标。 今年4月底，证监会IPO辅导公示系统显示，粤芯半导体技术股份有限公司提交IPO辅导备案，正式启动 A股上市进程，这已是今年上峰投资的企业中第五家正式启动上市的半导体企业，之前上海超硅IPO辅 导已通过验收，盛合晶微和芯耀辉已进入辅导，最快的昂瑞微申报科创板上市已获受理，加上已上市减 持退出的合肥晶合，上峰半导体产业链投资标的中近半数已开始对接A股市场，这是在近年审批节奏从 紧条件下上峰体现的高效投资效率，而后续长鑫存储等已完成股改的半导体龙头企业也同样值得期待。 | 7 | 摩尔精英 | 2021.5 | 2,224 | 芯片 | - | | --- | --- | --- | --- | --- | --- | | | | | | 供应 | ...

Core Viewpoint - Huayi Group plans to acquire 60% of Shanghai Huayi San Aifu New Materials Co., Ltd. for 4.091 billion yuan, aiming to enhance its strategic layout in emerging fields such as new energy and new materials [2][3][4] Group 1: Acquisition Details - The acquisition involves a cash payment of 4.091 billion yuan for 60% equity in San Aifu, which is a related party as it is controlled by Huayi Group's major shareholder [3][4] - San Aifu, established in September 2016 with a registered capital of 2.586 billion yuan, specializes in fluoropolymers and fluorinated chemicals [4][7] - The transaction is classified as a related party transaction due to the close ties between Huayi Group and Shanghai Huayi [3][4] Group 2: Strategic Importance - The acquisition is part of Huayi Group's strategy to focus on four emerging sectors: new energy, new materials, new environmental protection, and new biology [3][8] - Huayi Group aims to create a dual-driven development model by integrating basic chemicals and high-end fluorine materials, enhancing synergy between upstream and downstream operations [9][11] Group 3: Financial Performance - In 2023 and 2024, San Aifu reported revenues of 5.29 billion yuan and 4.62 billion yuan, with net profits of 344 million yuan and 253 million yuan, respectively [11] - Despite a decline in revenue and profit in 2024 due to market fluctuations and price drops, San Aifu maintains strong profitability [11] Group 4: Market Position and Potential - San Aifu holds a leading market position in high-end organic fluorine chemicals, with significant market shares in products like PVDF and FKM [10] - The company has developed advanced materials for strategic industries such as semiconductors and has a strong presence in the fourth-generation refrigerant market [10][11]

Core Insights - The company achieved a revenue of 5.921 billion yuan in 2024, representing a year-on-year growth of 25.57% and a net profit attributable to shareholders of 1.557 billion yuan, up 35.29% [1] - The company is driven by a dual engine of pharmaceutical and health consumer products, with significant growth in its core product lines [2] - The company has introduced an employee stock incentive plan to enhance talent attraction and promote long-term high-quality development [2] Financial Performance - In 2024, the company reported a net operating cash flow of 2.171 billion yuan, reflecting an 11.13% increase year-on-year [1] - The basic earnings per share (EPS) for 2024 was 2.42 yuan, marking a 35.20% increase compared to the previous year [1] - The company maintained a strong financial structure with a debt-to-asset ratio of 21.05% and cash reserves of 5.015 billion yuan at the end of the year [2] Business Segments - Revenue from the company's Ejiao and related products reached 5.544 billion yuan, a year-on-year increase of 27.04%, with a gross margin of 73.61% [2] - Other pharmaceuticals and health products generated revenue of 236 million yuan, up 26.19% year-on-year [2] - The company experienced a decline in revenue from donkey breeding and sales, which amounted to 69 million yuan, down 28.92% [2] Growth Initiatives - The company launched a stock incentive plan, proposing to grant up to 124.72 million restricted shares, representing 0.19% of the total share capital, to 179 key personnel [2] - The performance targets for the incentive plan include a compound annual growth rate of net profit attributable to shareholders of no less than 15% from 2025 to 2027 [2] - The company has a history of high dividends, with a mid-year dividend of 737 million yuan in 2024, representing 99.77% of the net profit attributable to shareholders for the first half of the year [2] Investment Outlook - The company is expected to achieve EPS of 2.87 yuan, 3.40 yuan, and 4.02 yuan for the years 2025 to 2027, with corresponding dynamic P/E ratios of 21.91, 18.53, and 15.66 [3] - As a leader in the Ejiao industry, the company possesses strong brand barriers and is anticipated to achieve steady growth in performance [3]

证券研究报告 | 2025年04月30日 华泰证券（601688.SH） 优于大市 自营反转，科技赋能 华泰证券公布 2025 年一季度报告。2025 年一季度，公司实现营业收入 82.32 亿元，同比提升 34.83%；实现归母净利润 36.42 亿元,同比提升 58.97%；扣 除非经常性损益后的净利润为 36.14 亿元，同比提升 61.42%，对应 EPS0.38 元，同比增长 58.33%；ROE 为 2.1%，同比增 0.73pct。业绩上涨主要因资本 市场回暖，公司财富管理、机构业务、投资管理及信用业务等主要业务线均 同比显著增长，后续公司持续推进科技赋能下的"双轮驱动"发展战略，围 绕数字化、平台化、生态化理念，完善 FICC 代客体系，探索"AI 智能提升"， "业务+科技"交融提升价值。 自营、利息业绩成业绩增长主要驱动力。一季度，因权益、衍生品、股权市 场回暖，投资规模和收益率增长驱动投资收入大幅提升，当期实现投资业务 收入（含公允价值变动）9.65 亿元，同比提升 46.53%；公司金融资产规模 3855 亿元，比 2024 年末提升 4.24%。一季度，利息净收入 9.65 亿元，同 ...

证券研究报告 | 2025年04月30日 华泰证券（601688.SH） 优于大市 自营反转，科技赋能 华泰证券公布 2025 年一季度报告。2025 年一季度，公司实现营业收入 82.32 亿元，同比提升 34.83%；实现归母净利润 36.42 亿元,同比提升 58.97%；扣 除非经常性损益后的净利润为 36.14 亿元，同比提升 61.42%，对应 EPS0.38 元，同比增长 58.33%；ROE 为 2.1%，同比增 0.73pct。业绩上涨主要因资本 市场回暖，公司财富管理、机构业务、投资管理及信用业务等主要业务线均 同比显著增长，后续公司持续推进科技赋能下的"双轮驱动"发展战略，围 绕数字化、平台化、生态化理念，完善 FICC 代客体系，探索"AI 智能提升"， "业务+科技"交融提升价值。 自营、利息业绩成业绩增长主要驱动力。一季度，因权益、衍生品、股权市 场回暖，投资规模和收益率增长驱动投资收入大幅提升，当期实现投资业务 收入（含公允价值变动）9.65 亿元，同比提升 46.53%；公司金融资产规模 3855 亿元，比 2024 年末提升 4.24%。一季度，利息净收入 9.65 亿元，同 ...

Group 1: Company Strategy and Market Position - In 2025, Dong'e Ejiao will focus on the "1238" strategy, emphasizing "growth and breakthrough" as its operational theme, and will implement the "four remakes" to enhance the entire gelatin industry chain [1] - The company holds a combined market share of 38.1% in the Qi and Xue supplement category, with Dong'e Ejiao block at 67.3% and Compound Ejiao Syrup at 31.9% [2] - Dong'e Ejiao aims to strengthen its core business and expand potential products through differentiated innovation and the establishment of technological barriers [1][2] Group 2: Financial Performance and Revenue - In Q1 2025, the company achieved online revenue of approximately 340 million yuan, a year-on-year increase of about 20% [2] - The online revenue breakdown includes: Ejiao block at approximately 120 million yuan (up nearly 15%), Compound Ejiao Syrup at approximately 60 million yuan (up nearly 60%), and Ejiao powder at approximately 60 million yuan (up nearly 50%) [2] - The overall gross margin is maintained at around 70%, with a slight increase in Q1 due to reduced costs from centralized procurement [7] Group 3: Inventory and Sales Management - The reasonable inventory level for Dong'e Ejiao block and Compound Ejiao Syrup is set at six months of terminal market sales, while for Taohua Ji Ejiao cake, it is 1.5 months [2] - The current channel inventory is at a healthy level, and terminal pure sales are progressing steadily [2] Group 4: Future Plans and Dividends - Since its first dividend in 1999, the company has distributed a total of 8.469 billion yuan over 26 occasions, with an average payout ratio of 65.75% [6] - The proposed dividend for 2024 is 818 million yuan, with a payout ratio of 99.70% [6] - The company plans to maintain a stable and proactive dividend policy based on its operational development, profitability, cash flow, and shareholder interests [6] Group 5: Challenges and Adjustments - The increase in accounts receivable in Q1 2025 is attributed to the implementation of a credit management strategy and increased procurement costs for strategic materials [4] - The company is addressing the small proportion of insurance payments for Compound Ejiao Syrup and aims for sustainable growth in this area [5]

小米的新款EV"SU7 Ultra"（Reuters） 3月22日，韩国三星电子会长李在镕来到小米在北京的EV工厂，并与小米首席执行官（CEO）雷 军会面。 三星寻找合作机会 三星和小米在智能手机领域展开了激烈的份额竞争。对未来经营抱有强烈危机感的李会长正在寻 找与在EV领域崛起的小米开展合作的契机，中国的主要媒体报道了这样的观点。 李在镕来到北京的目的是出席中国政府邀请全球大型企业高层参加的"中国发展高层论坛"。李在 镕的行为，彰显了小米在汽车市场的强劲势头和强大的存在感。 小米新涉足EV市场刚刚约一年时间。"特斯拉杀手"的称号名不虚传。根据中国知名汽车信息APP 的数据，2024年4月以来，SU7的中国销量达到了约18.6万辆，超过了特斯拉的Model 3。 SU7的价格为21.59万元起，比Model 3的23.55万起更便宜。其时尚的外观和性能的平衡受到了 消费者的追捧。 | 小米 | | 特斯拉 | | --- | --- | --- | | SU7 | | Model3 | | | SU7与Model3的 对比 | | | 21万5900~ | 价格 | 23万5500~ | | 29万9900元 ...

Core Insights - The company reported strong financial performance for Q1 2025, with revenue of 794 million yuan, a year-on-year increase of 37.77%, and a net profit of 101 million yuan, up 105.19% [1] - The company has established a dual-driven development model focusing on traditional seasoning products and emerging technology sectors, enhancing its market position and future growth potential [3] Financial Performance - For the fiscal year 2024, the company achieved a revenue of 2.646 billion yuan, representing a year-on-year growth of 25.98%, and a net profit of 203 million yuan, up 55.92%, marking a historical high since its listing [4] - The net profit after excluding non-recurring gains and losses was also 203 million yuan, reflecting a growth of 72.36% year-on-year [4] Business Expansion - The company’s core products, including monosodium glutamate, chicken essence, and flour, maintained leading market shares, with 198,100 tons of MSG and 30,800 tons of chicken essence sold in 2024 [2] - Online sales revenue surged by 165.68%, with new retail channels covering major platforms like Tmall, JD.com, and Douyin, significantly enhancing brand influence [2] Technological Advancements - The newly established intelligent computing center business became a highlight, generating revenue of 80.64 million yuan, a staggering increase of 10,447.11% year-on-year, with 34 signed projects worth over 1.5 billion yuan [2] - The company has completed the layout of intelligent computing centers in nine locations, covering key economic regions, and its self-developed cloud computing platform received the "2024 Annual China IDC Innovative Technology Product Award" [2] Strategic Outlook - The company aims for a revenue and profit growth of over 30% in 2025, further solidifying its dual-driven development model [3] - The significant increase in operating cash flow, reaching 652 million yuan, up 781.19% year-on-year, provides a solid foundation for strategic investments [3]

Core Viewpoint - Dong-E E-Jiao Co., Ltd. has shown strong financial performance in 2024, driven by dual growth in pharmaceutical and health consumer products, leading to a buy rating from Zhonghang Securities [1][5]. Financial Performance - In 2024, the company achieved operating revenue of 5.921 billion yuan, a year-on-year increase of 25.57% - The net profit attributable to shareholders reached 1.557 billion yuan, up 35.29% - The net profit after deducting non-recurring gains and losses was 1.442 billion yuan, an increase of 33.17% - Operating cash flow net amount was 2.171 billion yuan, growing by 11.13% - Basic earnings per share were 2.42 yuan, reflecting a growth of 35.20% [1][2]. Business Segments - Revenue from E-Jiao and related products was 5.544 billion yuan, up 27.04%, with a gross margin of 73.61% - Other pharmaceuticals and health products generated 236 million yuan, a growth of 26.19% - Revenue from donkey breeding and sales decreased by 28.92% to 69 million yuan - E-Jiao blocks saw double-digit growth, while compound E-Jiao syrup achieved over 50% growth, with the medical market outpacing retail - The core health consumer brand, Taohua Ji, expanded by over 10% through partnerships with leading health snack brands - E-Jiao powder experienced a remarkable growth of over 75% through focused branding and digital marketing strategies [2]. Incentive Plan - On January 10, 2025, the company announced a restricted stock incentive plan, proposing to grant up to 1.2472 million shares, accounting for 0.19% of total equity - The initial grant price is set at 37.22 yuan per share, targeting 179 individuals including directors and key personnel - Performance targets include a compound annual growth rate of net profit of no less than 15% from 2023 to 2025-2027, and net asset returns of at least 11.50%, 12.00%, and 12.50% for the respective years [3]. Dividend Policy - The company maintains a strong financial structure with a debt-to-asset ratio of 21.05% and cash reserves of 5.015 billion yuan - In September 2024, the company executed its first-ever interim dividend, distributing 737 million yuan, which is 99.77% of the net profit attributable to shareholders for the first half of 2024 - The annual dividend plan for 2024 is approximately 818 million yuan, representing 99.70% of the undistributed net profit for the year [4]. Investment Outlook - The company is expected to achieve earnings per share of 2.87 yuan, 3.40 yuan, and 4.02 yuan for 2025-2027, with corresponding dynamic price-to-earnings ratios of 21.91, 18.53, and 15.66 - As a leader in the E-Jiao industry, the company possesses strong brand barriers and is anticipated to achieve steady growth, leading to a buy rating [5].

天风证券（601162）股份有限公司鲍荣富,王涛,林晓龙近期对上峰水泥（000672）进行研究并发布了研究报告 《24年分红提升亮眼，25Q1连续两季度利润同比大增，新五年规划开启"双轮驱动"新征程》，给予上峰水泥买 入评级。 上峰水泥 主业来看，24年公司实现水泥及熟料收入同比-10.8%达47.64亿元，销量同比-3.3%达2075万吨，测算吨均价同 比下降19元至230元，受煤炭成本下降以及公司成本控制较优影响，吨成本同比下降13元至175元，最终吨毛利 同比下降5.8元至55元，测算吨净利同比下降3元达18元。两翼来看，24年公司骨料/环保处置业务有下滑，收入 同比分别-35%/-39%达3.2/1.4亿元，毛利率同比分别-4.6/-18.3pct达66.2%/37.8%。新经济股权投资方面成效凸 显，逐步进入收获期，晶合集成项目已完成并获得投资收益1.66亿元，光智科技（300489）公告拟并购先导电 科，昂瑞微申报科创板上市获受理，中润光能申报港股上市获受理，上海超硅上市辅导通过验收，盛合晶微、 芯耀辉进入申报上市辅导阶段，截至24年底已投资24个优质项目累计投资额超过17亿元。公司发布25-29 ...